CN Patent

CN114437043B — 一种抗新冠药物Nirmatrelvir的制备方法

Assigned to Zhejiang Lepu Pharmaceutical Co ltd · Expires 2023-06-16 · 3y expired

What this patent protects

本发明公开了一种抗新冠药物Nirmatrelvir(化合物I)的制备方法。该制备方法以便宜易得的三氟乙酰‑L‑叔亮氨酸(化合物II)为起始原料，经过若干步反应即可得到Nirmatrelvir。本发明具有工艺简单可靠、综合成本低和易于商业化生产等优点。

USPTO Abstract

本发明公开了一种抗新冠药物Nirmatrelvir(化合物I)的制备方法。该制备方法以便宜易得的三氟乙酰‑L‑叔亮氨酸(化合物II)为起始原料，经过若干步反应即可得到Nirmatrelvir。本发明具有工艺简单可靠、综合成本低和易于商业化生产等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN114437043B
Jurisdiction
CN
Classification
—
Expires
2023-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Lepu Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.